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Complex multimorbidity and health outcomes in older adult cancer
survivorsa

1. Department of Sociology, 711

David F. Warner1, Nicholas K. Schiltz2, Kurt C. Stange3,6, Charles W. Given4, Cynthia
Owusu5,6, Nathan A. Berger5,6, Siran M. Koroukian2,6

Oldfather Hall, University of Nebraska–Lincoln, 1400 R St., Lincoln, NE 68588, USA
2. Department of Epidemiology
and Biostatistics, School of Medicine, Wood Building, Case Western
Reserve University, 10900 Euclid

Abstract

Ave., Cleveland, OH 44106, USA

Objective: To characterize complex multimorbidity among cancer survivors and evaluate the
association between cancer survivorship, time since cancer diagnosis, and self-reported fair/poor
health, self-rated worse health in 2 years, and 2-year mortality.
Methods: We used the 2010–2012 Health and Retirement Study. Cancer survivors were individuals who reported a (nonskin) cancer diagnosis 2 years or more before the interview. We defined
complex multimorbidity as the co-occurrence of chronic conditions, functional limitations, and/or
geriatric syndromes. In addition to descriptive analyses, we used logistic regression to evaluate the
independent association between cancer survivor status and health outcomes. We also examined
whether cancer survivorship differed by the number of years since diagnosis.
Results: Among 15,808 older adults (age ≥50 years), 11.8% were cancer survivors. Compared
with cancer-free individuals, a greater percentage of cancer survivors had complex multimorbidity:
co-occurring chronic conditions, functional limitations, and geriatric syndromes. Cancer survivorship was significantly associated with self-reported fair/poor health, self-rated worse health in 2
years, and 2-year mortality. These effects declined with the number of years since diagnosis for fair/
poor health and mortality but not for self-rated worse health.
Conclusion: Cancer survivor status is independently associated with more complex multimorbidity, and with worse health outcomes. These effects attenuate with time, except for patient
perception of being in worse health.
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as a “complex health profile.” Many of the comorbidities

well as the previously documented cumulative effect of these

acquired after cancer may be associated with chemotoxicity

conditions relative to health outcomes, including self-reported

[5–7], and effects of hormonal treatment [8–10] or radiation

fair/poor health, self-reported worse heath in 2 years, and

treatment [11–14]. In addition to chronic medical conditions,

2-year mortality [22].

poor mental-health-related quality of life is more prevalent

This study has two objectives: (1) to characterize cancer

among cancer survivors than among cancer-free adults [15],

survivors’ complex multimorbidity profile; and (2) to evalu-

and clinically meaningful levels of depression and anxi-

ate the independent association between cancer survivor sta-

ety have been reported across subgroups of cancer survivors

tus and short-term poor health outcomes, including fair/poor

[16–18].

self-reported health, self-rated worse health in 2 years, and

A conference held jointly by the Cancer and Aging

2-year mortality. We hypothesize that after adjustment for the

Research Group, the National Cancer Institute, and the

multimorbidity profile and potential confounders, cancer sur-

National Institute on Aging provided a “framework for

vivor status remains associated with worse health outcomes.

future research to improve the evidence base for the clini-

Furthermore, we hypothesize that the association between

cal care of older adults with cancer” [19]. In it, the group

cancer survivor status and health outcomes is attenuated as

identified the first knowledge gap to be the lack of geriatric

more time has elapsed since cancer was first diagnosed.

assessment-guided interventions to improve outcomes for
by the American Society of Clinical Oncology highlighted

Methods
Overview

“relative lack of research” involving older cancer survivors

This is a short-term study using 2010–2012 data from the

(current age >65 years) [20]. To fill these gaps, however, a

HRS to compare complex multimorbidity and health out-

more comprehensive assessment is needed to evaluate not

comes between cancer survivors and cancer-free individuals.

only the chronic condition comorbidity burden among older

Since the data originate from the public use files of the HRS,

cancer survivors but also their complex multimorbidity bur-

this study was deemed exempt by the Case Western Reserve

den to account for difficulty with physical functioning and

University Institutional Review Board.

older patients with cancer. Another report from a survey

geriatric syndromes, in addition to their chronic conditions.
Such a comprehensive approach in studying the health pro-

Data source

file of older cancer survivors is all the more important given

We used 2010–2012 data from the public use files of the HRS.

the role of cancer in further functional decline and increased

The HRS is the largest longitudinal survey study in the United

risk of depression [21].

States, with data on nearly 30,000 US adults aged 50 years or

In this study, we use data from the Health and Retirement

older. Every 2 years, HRS participants are asked to report on

Study (HRS), a longitudinal panel launched in 1992, through

chronic conditions, functional status, cognitive status, depres-

which a rich array of data are collected biennially on a US

sive symptoms, and a range of behavioral variables.

representative sample of adults aged 50 years or older. We take
advantage of the rich HRS data to define complex multimor-

Study population

bidity as the occurrence or co-occurrence of chronic condi-

All HRS participants were eligible to be included in the study.

tions, functional limitations, and/or geriatric syndromes (e.g.,

Respondents with a new (incident) cancer diagnosis in 2010, as

poor cognitive functioning, and incontinence). With this more

defined below, were excluded from the study. Respondents had

expansive definition of multimorbidity, we move away from

to be self-reporting in 2010, and any proxy respondents were

prior studies’ sole reliance on multiple chronic conditions. In

excluded. Our study population included 15,808 individuals

addition, we acknowledge the cascading effects of chronic

(2025 cancer survivors, and 13,783 cancer-free individuals).

conditions that manifest themselves in the emergence or wors-

The average time elapsed since diagnosis for cancer survivors

ening of functional limitations and geriatric syndromes, as

was slightly more than 12 years.
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Variables of interest

depressive symptoms on the Center for Epidemiological
Studies Depression Scale; incontinence; visual impairment;

Outcome variables: The following were our outcome vari-

hearing impairment; persistent dizziness, and severe pain. For

ables:

individuals aged 65 years or older, we also accounted for falls

•
•

•

Self-reported fair or poor health status in 2010 (versus

as part of geriatric syndromes; respondents younger than 65

excellent, very good, or good)

years were not asked about falls.

Self-rated 2-year decline, coded as ‘1’ if the participant

On the basis of our previous work [22, 23] showing that the

rates his/her health as “worse” (versus “better” or “about

co-occurrence of chronic conditions, functional limitations,

the same”) in 2012 compared with when he or she was

and geriatric syndromes had a cumulative effect on health

interviewed in 2010

outcomes, we derived a composite measure for complex mul-

Two-year mortality, based on deceased status in 2012,

timorbidity, defined as follows: MM0 in the absence of any

as reported by the spouse or another relative or through

of the aforementioned conditions; MM1 in the presence (but

probabilistic matching with the National Death Index

without the co-occurrence) of chronic conditions, functional
limitations, or geriatric syndromes; MM2 when conditions

Independent variables: Our main independent variable

across two of the domains of chronic conditions, functional

was cancer survivor status, coded as ‘1’ if the respondent

limitations, and geriatric syndromes co-occur; and MM3

reported a (nonskin) cancer diagnosis at least 2 years before

when conditions across all three of these domains co-occur.

the interview. Otherwise participants were defined as cancer-

This composite measure has been shown to be associated with

free individuals. We coded the time elapsed since cancer diag-

the outcomes of interest in a dose–response fashion.

nosis as 2–4 years, 5–9 years, and 10 years or more; alternative

Other independent variables include age (grouped in 5-year

coding, including a linear specification, yielded similar results.

increments), race/ethnicity (white non-Hispanic, black non-

Respondents who reported a new cancer diagnosis within the

Hispanic, Hispanic, and other), sex (male and female), mari-

prior 2 years were excluded.

tal status (married, divorced, widowed, and never married),

Complex multimorbidity was characterized by the presence

number of years of education (<9, 9–11, 12, 13–15, 16, and

and co-occurrence of chronic conditions, functional limita-

≥17), and income as a percentage of the federal poverty level

tions, and/or geriatric syndromes in 2010, consistent with our

(<100%, 100%–199%, 200%–299%, ≥300%). Behavioral

previous work [22]. Self-reported chronic conditions included

variables include smoking status (never smoked, former

hypertension, arthritis, heart disease, lung disease, diabetes,

smoker, and current smoker), vigorous exercise (“sports or

stroke, and psychiatric disorders. These conditions were con-

activities that are vigorous” at least once per week), alcohol

sidered present if the respondent replied in the affirmative to

use based on average number of drinks per day (none; moder-

the question: “Has the doctor ever told you that you have” one

ate, one or two drinks; heavy, three or more drinks), and body

of the above conditions?

mass index, defined as weight in kilograms divided by the

Functional limitations included self-reported “any difficulty” in upper body mobility (e.g., reaching or extending

square of height in meters (underweight, ≤18 kg/m2; normal/
overweight, 18–29 kg/m2; obese, ≥30 kg/m2).

arms above shoulder level); lower body mobility (e.g., walking
several blocks or difficulty climbing stairs); strength (e.g., lift-

Analytic strategy

ing 10 lb); activities of daily living (e.g., eating, dressing, bath-

In addition to descriptive analysis, we conducted multivari-

ing); and instrumental activities of daily living (e.g., preparing

able logistic regression analysis to analyze the independent

meals or managing oral medications).

association between cancer survivorship and health outcomes,

Geriatric syndromes included poor cognitive per-

after adjustment for multimorbidity and other potential con-

formance (rated in the bottom tertile on the Telephone

founders. We estimated two sets of multivariable models. The

Interview for Cognitive Status); depression (at least four

first examined the association between cancer survivor status

131 
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and the health outcomes; the second examined the associa-

Table 3 shows the distribution of the study population by the

tion between the time since cancer diagnosis and the health

complex multimorbidity composite score, as well as health out-

outcomes. Cancer-free individuals were the reference in both

comes, by cancer survivor status. Not surprisingly, compared

sets of models.

with cancer-free individuals, a significantly greater percent-

We applied survey weights to account for the complex sur-

age of cancer survivors presented with co-occurring chronic

vey design of the HRS. SAS® version 9.4 was used in all of our

conditions, functional limitations, and geriatric syndromes,

analyses.

or MM3 (34.02% vs. 25.12%), reported fair/poor health status (34.79% vs. 25.55%), and rated their health as “worse”

Results

than that 2 years previously (29.34% vs. 21.42%, P<0.001 for

The distribution of the study population by sociodemographic

all comparisons). Two-year mortality was more than double

variables is presented in Table 1. Cancer survivors accounted

among cancer survivors compared with among cancer-free

for 12.81% of participants. A greater percentage of cancer sur-

individuals (7.60% and 3.26% respectively, P<0.001).

vivors than cancer-free individuals were aged 70 years or older

The findings from our multivariable logistic regression

(60.79% vs. 34.64%) and white non-Hispanic (76.69% vs.

analysis showed that the differences in health outcomes

63.56%); P<0.001 for both comparisons. No marked differ-

by cancer survivor status persisted after adjustment for

ences were observed by marital status, education, or income.

age and complex multimorbidity status. Thus, as shown in

Importantly, however, compared with cancer-free individuals,

Fig. 1, cancer survivors were significantly likelier to report

a significantly greater percentage of cancer survivors were

fair/poor health [adjusted odds ratio 1.73, 95% confidence

former smokers (48.20% vs. 39.96%), and fewer engaged in

interval (CI) 1.49–2.01] or 2-year self-rated worse health

vigorous exercise (20.74% vs. 25.59%).

(adjusted odds ratio 1.32, 95% CI 1.15–1.51), or to die within

Table 2 presents the percentage of individuals present-

2 years (adjusted odds ratio 1.51, 95% CI 1.16–1.96). Despite

ing with the various chronic conditions, functional limita-

the higher levels of multimorbidity among cancer survivors,

tions, and geriatric syndromes by cancer survivor status.

preliminary analyses (not shown) did not detect a statisti-

Regardless of the condition, the percentage of individu-

cally significant interaction between cancer survivorship

als presenting with the condition was significantly higher

and multimorbidity for any of the outcomes. Thus, the effect

among cancer survivors than among cancer-free individuals.

of multimorbidity on the health outcomes was not stronger

However, the greatest differentials between the two groups

(or weaker) for cancer survivors compared with cancer-free

were for arthritis (67.65% vs. 52.98%) and heart disease

individuals.

(35.46% vs. 23.20%). Similarly, a greater percentage of can-

The analyses examining the effect of time since diagnosis

cer survivors than their cancer-free counterparts reported

showed that the increased likelihood of self-reported fair/poor

strength limitations, upper body mobility limitations, lower

health and 2-year mortality was generally lower the more time

body mobility limitations, and limitations in independent

that had elapsed (Fig. 2). Cancer survivors 10 years or more

activities of daily living. The differential between the two

after diagnosis had odds of death that did not differ from that

groups was the smallest for limitations in activities of daily

of cancer-free individuals. Cancer survivors 5–9 years and 10

living (4.59% vs. 3.58%, P=0.03; P<0.001 for all other com-

years or more after diagnosis did not differ from one another

parisons). With regard to geriatric syndromes, we observed

in self-reported fair/poor health but remained different from

statistically significant differences between cancer survivors

cancer-free individuals. There were no differences in the per-

and cancer-free individuals with respect to incontinence

ception of being in worse health by the time since diagnosis.

(32.74% vs. 20.76%), severe pain (8.59% vs. 6.38%), hearing

Combined with the results from Fig. 1, this indicates that

impairment (24.59% vs. 18.56%), and poor cognitive func-

cancer survivors were slightly more likely to rate their health

tioning (33.30% vs. 31.10%, P=0.047; all other comparisons

worse than that 2 years previously regardless of the time since

significant at P<0.01).

diagnosis.
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Table 1. Sociodemographic characteristics and health outcomes among cancer survivors and cancer-free individuals
Variables of interest

Cancer survivors

Cancer-free individuals

Total

Age category
50–54

138 (6.81%)

2550 (18.50%)

2688 (17.00%)

55–59

180 (8.89%)

2800 (20.31%)

2980 (18.85%)

60–64

227 (11.21%)

2025 (14.69%)

2252 (14.25%)

65–69

249 (12.30%)

1635 (11.86%)

1884 (11.92%)

70–74

385 (19.01%)

1951 (14.16%)

2336 (14.77%)

75–79

359 (17.73%)

1346 (9.77%)

1705 (10.79%)

80–84

275 (13.58%)

817 (5.93%)

1092 (6.91%)

≥85

212 (10.47%)

659 (4.78%)

871 (5.51%)

Sexa
Male

863 (42.62%)

5751 (41.73%)

6614 (41.84%)

1162 (57.38%)

8032 (58.27%)

9194 (58.16%)

White non-Hispanic

1553 (76.69%)

8761 (63.56%)

10314 (65.25%)

Black non-Hispanic

286 (14.12%)

2762 (20.04%)

3048 (19.28%)

148 (7.31%)

1828 (13.26%)

1976 (12.50%)

38 (1.88%)

432 (3.13%)

470 (2.97%)

Married

1213 (59.90%)

8521 (61.82%)

9734 (61.58%)

Divorced

288 (14.22%)

2785 (15.85%)

2473 (15.64%)

Widowed

437 (21.58%)

2209 (16.03%)

2646 (16.74%)

87 (4.30%)

868 (6.30%)

955 (6.04%)

159 (7.85%)

1216 (8.82%)

1375 (8.70%)

Female
Race/ethnicity

Hispanic
Other
Marital status

Never married
Education (years)b
<9
9–11

240 (11.85%)

1564 (11.35%)

1804 (11.41%)

12

674 (33.28%)

4392 (31.87%)

5066 (32.05%)

13–15

456 (22.52%)

3361 (24.38%)

3817 (24.15%)

16

246 (12.15%)

1683 (12.21%)

1929 (12.20%)

≥17

250 (12.35%)

1567 (11.37%)

1817 (11.49%)

Income as percentage of federal poverty levelc
<100%
100%–199%
200%–299%

199 (9.83%)

1716 (12.45%)

1915 (12.11%)

417 (20.59%)

2633 (19.11%)

3050 (19.29%)

373 (18.42%)

2269 (16.46%)

2642 (16.72%)

1036 (51.16%)

7165 (51.98%)

8201 (51.88%)

Never smoked

829 (40.94%)

6106 (44.30%)

6935 (43.87%)

Former smoker

976 (48.20%)

5508 (39.96%)

6484 (41.02%)

Current smoker

220 (10.86%)

2169 (15.74%)

2389 (15.11%)

1298 (64.10%)

8531 (61.90%)

9829 (62.18%)

609 (30.07%)

3857 (27.98%)

4466 (28.25%)

118 (5.83%)

1395 (10.12%)

1513 (9.57%)

≥300%
Smoking statusb

Alcohol use
None
Moderate
Heavy
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Table 1 (continued)
Variables of interest

Cancer survivors

Cancer-free individuals

Total

Missing

18 (0.89%)

259 (1.88%)

277 (1.75%)

Underweight

35 (1.73%)

134 (0.97%)

169 (1.07%)

1322 (65.28%)

8539 (61.95%)

9862 (62.38%)

650 (32.10%)

4851 (35.20%)

5501 (34.80%)

No

1605 (79.26%)

10,256 (74.41%)

11,861 (75.03%)

Yes

420 (20.74%)

3527 (25.59%)

3947 (24.97%)

2025 (100.00%)

13,783 (100.00%)

15,808 (100.00%)

Body mass index (kg/m2)c

Normal/overweight
Obese
Vigorous exercisec

Total

Unless indicated otherwise, (unadjusted) comparisons were significant at P<0.0001.
P>0.05.

a

b

0.05≤P<0.01.

0.01≤P<0.001.

c

Table 2. Conditions constituting multimorbidity, by cancer survivor status
Conditions of interest

Cancer survivors

Cancer-free individuals

Total

Chronic conditions
Hypertension

1369 (67.60%)

8204 (59.52%)

9573 (60.56%)

Arthritis

1370 (67.65%)

7302 (52.98%)

8672 (54.86%)

Heart disease

718 (35.46%)

3197 (23.20%)

3915 (24.77%)

Lung disease

280 (13.83%)

1216 (8.82%)

1496 (9.46%)

Stroke

253 (12.49%)

1102 (8.00%)

1355 (8.57%)

Diabetes

553 (27.31%)

3116 (22.61%)

3669 (23.21%)

Psychiatric conditions

396 (19.56%)

2197 (15.94%)

2593 (16.40%)

Functional limitations
1302 (64.30%)

7443 (54.00%)

8745 (55.32%)

Upper body mobility limitations

Strength limitations

828 (40.89%)

4379 (31.77%)

5207 (32.94%)

Lower body mobility limitations

1377 (68.00%)

7723 (56.03%)

9100 (57.57%)

Limitations in ADLsa

93 (4.59%)

494 (3.58%)

587 (3.71%)

Limitations in IADLs

373 (18.42%)

1830 (13.28%)

2203 (13.94%)

Low cognitive functioninga

675 (33.33%)

4287 (31.10%)

4961 (31.38%)

Depressive symptomsb

313 (15.46%)

1994 (14.47%)

2307 (14.59%)

Incontinence

663 (32.74%)

2862 (20.76%)

3525 (22.30%)

Severe pain

174 (8.59%)

879 (6.38%)

1053 (6.66%)

Visual impairmentd

485 (23.95%)

3105 (22.53%)

3590 (22.71%)

Hearing Impairment

498 (24.59%)

2558 (18.56%)

3056 (19.33%)

2025 (100.00%)

13,783 (100.00%)

15,808 (100.00%)

Geriatric syndromes

Total

Unless indicated otherwise, (unadjusted) comparisons significant at P<0.001.
ADLs, activity of daily living; IADL independent activities of daily living.
0.05≤P<0.01

a

b

P>0.05.
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Table 3. Multimorbidity and health outcomes
Variables of interest

Cancer survivors

Cancer-free individuals

Total

Multimorbidity/composite measure
MM0

148 (7.31%)

1781 (12.92%)

1929 (12.20%)

MM1

482 (23.81%)

4196 (30.44%)

4678 (29.59%)

MM2

706 (34.86%)

4344 (31.52%)

5050 (31.95%)

MM3

689 (34.02%)

3462 (25.12%)

4151 (26.26%)

1220 (65.21%)

9927 (74.45%)

11,147 (73.31%)

651 (34.79%)

3407 (25.55%)

4058 (26.69%)

No

1322 (70.66%)

10,478 (78.58%)

11,800 (77.61%)

Yes

549 (29.34%)

2856 (21.42%)

3405 (22.39%)

No

1871 (92.40%)

13,334 (96.74%)

15,205 (96.19%)

Yes

154 (7.60%)

449 (3.26%)

603 (3.81%)

2025 (100.00%)

13,783 (100.00%)

15,808 (100.00)

Self-reported health statusa
Good/very good/excellent health
Fair/poor health
Two-year self-reported worse health

a

Two-year mortality

Total
All comparisons significant at P<0.001.

MM0, absence of chronic conditions, functional limitations, or geriatric syndromes; MM1 presence (but without the co-occurrence) of chronic
conditions, functional limitations, or geriatric syndromes; MM2, co-occurrence of conditions across two of the domains of chronic conditions,
functional limitations, and geriatric syndromes; MM3, co-occurrence of chronic conditions, functional limitations, and geriatric syndromes.
Reports limited to respondents alive and interviewed in 2012.

Adjusted odds ratio
and 95% confidence interval

a

2.5

survivors. However, cancer survivors were significantly older,

2.0

and a greater percentage of them were white non-Hispanic
– perhaps a reflection, downstream, of well-documented dis-

1.5

parities in cancer survival experienced by patients of minority

1.0

descent.

0.5

Even after adjustment for age, other sociodemographic

0.0
Self-reported
fair/poor health

Two-year self-rated
worse health

Two-year mortality

Fig. 1. Results from the multivariable analysis showing the

variables, and multimorbidity, cancer survivors were likelier
to report fair/poor health and 2-year worse health, or to have
died within 2 years. For health status, it is critically important

association between cancer survivor status and health outcomes, after

to determine whether self-reported fair/poor health is perceived

adjustment for sociodemographic characteristics and multimorbidity.

because of their past challenges or whether it reflects unmeasured conditions, such as fatigue. Here, the complex and somewhat paradoxical findings from Fig. 2 deserve some discussion.

Discussion

On one hand, with greater time elapsed since cancer diagnosis,

Consistent with previous studies [4], we documented a ‘com-

older cancer survivors become more similar to cancer-free indi-

plex health profile’ and a greater multimorbidity burden among

viduals in their reports of fair/poor health, possibly reflecting the

cancer survivors compared with their cancer-free counterparts.

‘suppression’ of their cancer experience, as they face the emer-

With the exception of limitations in activities of daily living,

gence of aging-related physical, functional, psychological, and

depressive symptoms, and visual impairment, we observed

emotional challenges [24]. On the other hand, the fact that can-

a higher percentage of various conditions among cancer

cer survivors are likelier to rate their health as having become
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Fig. 2. Results from the multivariable analysis showing the association between time elapsed since cancer diagnosis and health outcomes, after
adjustment for sociodemographic characteristics and multimorbidity.

worse in the previous 2 years regardless of the amount of time

Second, given their poor mental and physical health out-

since diagnosis, even as elevated levels of poor/fair health and

comes, cancer survivors may benefit from cognitive behavio-

mortality seem to recede, suggests that cancer survivorship fun-

ral therapy and physical activity interventions to improve their

damentally alters their perceptions of their current health rela-

functioning and health self-assessments. Such programs have

tive to the past. This phenomenon, described by Kahana et al.

proven highly effective [15, 29].

[25] as posttraumatic transformations, reflects cancer survivors’
view that cancer is a “continuing and worrisome experience.”

Third, it is important that survivorship care plans be tailored to individuals’ physical and mental health, as well as

For the most part, our findings are consistent with those of

psychosocial needs and preferences, and enhance their self-

previous studies, indicating poorer health and greater functional

efficacy [30]. As noted by Halpern and Argenbright [30],

impairment in cancer survivors. While we note that our study

survivorship programs should be evaluated on their long-term

population excludes cancer survivors in whom with cancer had

outcomes, including quality-adjusted life years and functional

been diagnosed within the last 2 years, the lack of association

status; receipt of social support, as well as nutritional and

between depressive symptoms and cancer survivor status in our

rehabilitative services; and as judicious use of health services

study differs from prior studies. These studies show that cancer

(i.e., avoidance of inappropriate use of resources).

survivors continue to perceive cancer’s threats to their quality
of life, even as they age into older adulthood [26].

Finally, given the increase in the number of cancer survivors
and their improved life expectancy, it is critically important to

Our study findings have important clinical implications.

determine whether self-assessed poor and worsening health

First, given cancer survivors’ complex multimorbidity profile,

reflects their past challenges or whether it signals unmeasured

the role of primary care physicians (PCPs) in coordinating care

health conditions, such as fatigue. Remedial measures can be

among the various medical specialists is a critical one, given

taken accordingly to improve their health status. As noted by

their responsibility to incorporate treatment summaries and sur-

Kahana et al. [25], “therapeutic exchanges” based on commu-

veillance regimens from their survivorship care plan [27]. While

nications between patients, health care providers, and mental

some prior studies have shown that PCPs can safely manage

health professionals about patients’ appraisal of their illness,

follow-up care in certain patient populations (e.g., early-stage

the life-changing nature of receiving a diagnosis of and being

breast cancer survivors), others have expressed preference for

treated for cancer, and stigma can be highly beneficial to the

a survivorship care co-managed by PCPs and oncologists [28].

patient.
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We note several limitations to our study. First, our study does

survivors. While care should be focused on both the physical

not account for the anatomic site of primary cancer, multiple pri-

and the psychological needs in the near term, cancer survivors

mary cancers, recurrences, or cancer stage at diagnosis for the

would greatly benefit from continued cognitive behavioral

first or subsequent cancers, and while cancer survivorship was

interventions to address persisting cancer-related stress.

based on self-report, specificity, high negative predictive value,
and general concordance between self-reported cancer and
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